Quantcast
- Advertisement -spot_img

TAG

Antibody

Novel IL-6 Antibody Slashes CRP up to 92% in High-risk ASCVD

Inhibition of interleukin (IL)-6 with ziltivekimab reduces multiple biomarkers of inflammation and thrombosis in patients at high atherosclerotic risk with moderate to severe chronic...

Latest news

- Advertisement -spot_img